Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enhanc3D Genomics has developed a proprietary high-resolution genome-wide mapping technology (GenLink3D) that connects non-coding genetic variants to their functional gene targets. The company’s approach enables the identification of new biomarkers and therapeutic targets for complex diseases such as cancer, autoimmune disorders, and ageing. No direct clinical results reported; focus remains on target/biomarker discovery for pharma partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enhanc3D Genomics.